Latent Space·
Genesis: AI drug discovery is a science of resolution
Evan Feinberg and Sergey Edunov· CEO and CTO of Genesis Molecular AI
Genesis Molecular AI's Evan Feinberg and Sergey Edunov explain how they ported the LLM scaling playbook to 3D molecular structure — synthetic physics data, inference-time 'thinking' in crystal structures, and agents — betting that sub-angstrom resolution is the threshold that turns AI drug discovery from pattern-matching into real medicines.
AI InfrastructureTrainingAgentsMultimodal